Literature DB >> 1575692

The application of a novel biotinylated affinity label for the detection of a cathepsin B-like precursor produced by breast-tumour cells in culture.

B M Cullen1, I M Halliday, G Kay, J Nelson, B Walker.   

Abstract

In this report we demonstrate how the recently developed biotinylated affinity label biotinyl-Phe-Ala-diazomethane (Bio-Phe-Ala-CHN2) [Cullen, McGinty, Walker, Nelson, Halliday, Bailie & Kay (1990) Biochem. Soc. Trans. 18, 315-316; Walker, Cullen, Kay, Halliday, McGinty & Nelson (1992) Biochem. J. 283, 449-453] can be used for the detection of a precursor form of a cathepsin B-like enzyme produced by breast-tumour cells in culture. Thus the cell lines MDA-MB-436, ZR-75-1 and T47-D produce a soluble protein that can be allowed to react with the biotinylated affinity label to yield an SDS-resistant complex; this can be revealed with a streptavidin/alkaline phosphatase label after PAGE and Western blotting. This protein (molecular mass 47 kDa) can also be detected by immunoblotting using sheep anti-(cathepsin B) antibodies in conjunction with a donkey anti-sheep IgG label. None of the cell lines studied produced any mature cathepsin B-like activity, as gauged by the lack of turnover of the fluorogenic substrate benzyloxycarbonyl-Arg-Arg-4-methylcoumarin-7-ylamide (Cbz-Arg-Arg-NH-Mec). However, treatment of medium samples with pepsin resulted in the generation of such activity. When the pepsin-catalysed activation step was analysed by SDS/PAGE, the protein of 47 kDa was completely converted into two species of very similar molecular masses of 30.5 kDa and 29 kDa. Both these proteins can incorporate the biotinylated probe and, in common with the 47 kD species, they can be detected with the streptavidin/alkaline phosphatase label and immunoblotting. We propose that the 47 kD form is the pepsin-activable proform of these lower-molecular-mass species. The release of the proform from the oestrogen-receptor (ER)-positive breast-tumour cell lines ZR-75-1 and T47-D is stimulated 5-10-fold when these cells are grown in medium containing epidermal growth factor (EGF) at a concentration of 10 ng/ml. In contrast, there is no modulation in the amount of proform released by the ER-negative cell line MDA-MB-436, over a range of EGF concentrations from 0 to 100 ng/ml.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1575692      PMCID: PMC1131057          DOI: 10.1042/bj2830461

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines.

Authors:  R A Maciewicz; R J Wardale; D J Etherington; C Paraskeva
Journal:  Int J Cancer       Date:  1989-03-15       Impact factor: 7.396

2.  Interrelationship of active and latent secreted human cathepsin B precursors.

Authors:  J S Mort; A D Recklies
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

3.  Transmission densitometry of stained nitrocellulose paper.

Authors:  R A Maciewicz; P J Knight
Journal:  Anal Biochem       Date:  1988-11-15       Impact factor: 3.365

4.  Biosynthesis of cathepsin B in cultured normal and I-cell fibroblasts.

Authors:  H Hanewinkel; J Glössl; H Kresse
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

5.  Active center differences between cathepsins L and B: the S1 binding region.

Authors:  H Kirschke; P Wikstrom; E Shaw
Journal:  FEBS Lett       Date:  1988-02-08       Impact factor: 4.124

6.  The major excreted protein (MEP) of transformed mouse cells and cathepsin L have similar protease specificity.

Authors:  S Gal; M M Gottesman
Journal:  Biochem Biophys Res Commun       Date:  1986-08-29       Impact factor: 3.575

7.  The major excreted protein of transformed fibroblasts is an activable acid-protease.

Authors:  S Gal; M M Gottesman
Journal:  J Biol Chem       Date:  1986-02-05       Impact factor: 5.157

8.  Purification and characterization of two different precursor forms of the cathepsin B-like proteinase from human malignant ascitic fluid.

Authors:  D Keppler; M Pagano; V Dalet-Fumeron; R Engler
Journal:  Biol Chem Hoppe Seyler       Date:  1988-05

9.  Comparative studies of two cathepsin B isozymes from porcine spleen. Isolation, polypeptide chain arrangements, and enzyme specificity.

Authors:  T Takahashi; S Yonezawa; A H Dehdarani; J Tang
Journal:  J Biol Chem       Date:  1986-07-15       Impact factor: 5.157

10.  Production of transforming growth factor-alpha in human tumour cell lines.

Authors:  K Imanishi; K Yamaguchi; M Suzuki; S Honda; N Yanaihara; K Abe
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

View more
  7 in total

1.  The synthesis, kinetic characterization and application of a novel biotinylated affinity label for cathepsin B.

Authors:  B Walker; B M Cullen; G Kay; I M Halliday; A McGinty; J Nelson
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

2.  Quantification of cathepsins B and L in cells.

Authors:  R Xing; A K Addington; R W Mason
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

3.  Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells.

Authors:  Lei Li; M Page Haynes; Jeffrey R Bender
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

Review 4.  Analysis of enzyme reactions in situ.

Authors:  C J Van Noorden; G N Jonges
Journal:  Histochem J       Date:  1995-02

5.  Peptide glyoxals: a novel class of inhibitor for serine and cysteine proteinases.

Authors:  B Walker; N McCarthy; A Healy; T Ye; M A McKervey
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

6.  Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages.

Authors:  V Y Reddy; Q Y Zhang; S J Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

7.  Irreversible inhibition of the bacterial cysteine protease-transpeptidase sortase (SrtA) by substrate-derived affinity labels.

Authors:  Christopher J Scott; Andrew McDowell; S Lorraine Martin; John F Lynas; Koen Vandenbroeck; Brian Walker
Journal:  Biochem J       Date:  2002-09-15       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.